LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.

    Zhang, Hannah / Léveillé, Mélissa / Courty, Emilie / Gunes, Aysim / N Nguyen, Bich / Estall, Jennifer L

    American journal of physiology. Endocrinology and metabolism

    2020  Volume 319, Issue 5, Page(s) E863–E876

    Abstract: Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic linked to metabolic disease. The first stage of NAFLD is characterized by lipid accumulation in hepatocytes, but this can progress into nonalcoholic steatohepatitis (NASH), cirrhosis, and ... ...

    Abstract Nonalcoholic fatty liver disease (NAFLD) is a growing epidemic linked to metabolic disease. The first stage of NAFLD is characterized by lipid accumulation in hepatocytes, but this can progress into nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC). Western diets, high in fats, sugars, and cholesterol, are linked to NAFLD development. Murine models are often used to study NAFLD; however, there remains debate on which diet-induced model best mimics both human disease progression and pathogenesis. In this study, we performed a side-by-side comparison of two popular diet models of murine NAFLD/NASH and associated HCC, a high-fat diet supplemented with 30% fructose water (HFHF) and a Western diet high in cholesterol (WDHC), and these were compared with a common grain-based chow diet (GBD). Mice on both experimental diets developed liver steatosis, and WDHC-fed mice had greater levels of hepatic inflammation and fibrosis than HFHF-fed mice. In contrast, HFHF-fed mice were more obese and developed more severe metabolic syndrome, with less pronounced liver disease. Despite these differences, WDHC-fed and HFHF-fed mice had similar tumor burdens in a model of diet-potentiated liver cancer. Response to diet and resulting phenotypes were generally similar between sexes, albeit delayed in females. This study shows that modest differences in diet can significantly uncouple glucose homeostasis and liver damage. In conclusion, long-term feeding of either HFHF or WDHC is a reliable method to induce NASH and diet-potentiated liver cancer in mice of both sexes; however, the choice of diet involves a trade-off between severity of metabolic syndrome and liver damage.
    MeSH term(s) Animals ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/pathology ; Diet, High-Fat ; Diet, Western ; Disease Models, Animal ; Disease Progression ; Female ; Hepatocytes/metabolism ; Hepatocytes/pathology ; Lipid Metabolism/physiology ; Liver/metabolism ; Liver/pathology ; Liver Neoplasms/etiology ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Male ; Mice ; Non-alcoholic Fatty Liver Disease/complications ; Non-alcoholic Fatty Liver Disease/metabolism ; Non-alcoholic Fatty Liver Disease/pathology
    Language English
    Publishing date 2020-09-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00321.2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Glucose Regulates m

    Bornaque, Florine / Delannoy, Clément Philippe / Courty, Emilie / Rabhi, Nabil / Carney, Charlène / Rolland, Laure / Moreno, Maeva / Gromada, Xavier / Bourouh, Cyril / Petit, Pauline / Durand, Emmanuelle / Pattou, François / Kerr-Conte, Julie / Froguel, Philippe / Bonnefond, Amélie / Oger, Frédérik / Annicotte, Jean-Sébastien

    Cells

    2022  Volume 11, Issue 2

    Abstract: Type 2 diabetes is characterized by chronic hyperglycemia associated with impaired insulin action and secretion. Although the heritability of type 2 diabetes is high, the environment, including blood components, could play a major role in the development ...

    Abstract Type 2 diabetes is characterized by chronic hyperglycemia associated with impaired insulin action and secretion. Although the heritability of type 2 diabetes is high, the environment, including blood components, could play a major role in the development of the disease. Amongst environmental effects, epitranscriptomic modifications have been recently shown to affect gene expression and glucose homeostasis. The epitranscriptome is characterized by reversible chemical changes in RNA, with one of the most prevalent being the m
    MeSH term(s) Adenosine/analogs & derivatives ; Adenosine/metabolism ; AlkB Homolog 5, RNA Demethylase/genetics ; AlkB Homolog 5, RNA Demethylase/metabolism ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO/metabolism ; Animals ; Cell Line ; Down-Regulation/drug effects ; Glucose/metabolism ; Glucose/pharmacology ; Insulin Secretion/drug effects ; Insulin-Secreting Cells/drug effects ; Insulin-Secreting Cells/metabolism ; Islets of Langerhans/drug effects ; Islets of Langerhans/metabolism ; Methylation/drug effects ; Mice ; Mice, Inbred C57BL ; Palmitates/pharmacology ; RNA/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
    Chemical Substances Palmitates ; RNA, Messenger ; RNA (63231-63-0) ; N-methyladenosine (CLE6G00625) ; AlkB Homolog 5, RNA Demethylase (EC 1.14.11.-) ; FTO protein, mouse (EC 1.14.11.-) ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO (EC 1.14.11.33) ; FTO protein, human (EC 1.14.11.33) ; Glucose (IY9XDZ35W2) ; Adenosine (K72T3FS567)
    Language English
    Publishing date 2022-01-15
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells11020291
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells.

    Bourouh, Cyril / Courty, Emilie / Rolland, Laure / Pasquetti, Gianni / Gromada, Xavier / Rabhi, Nabil / Carney, Charlène / Moreno, Maeva / Boutry, Raphaël / Caron, Emilie / Benfodda, Zohra / Meffre, Patrick / Kerr-Conte, Julie / Pattou, François / Froguel, Philippe / Bonnefond, Amélie / Oger, Frédérik / Annicotte, Jean-Sébastien

    Cell reports

    2022  Volume 40, Issue 6, Page(s) 111170

    Abstract: The glucagon-like peptide 1 (Glp-1) has emerged as a hormone with broad pharmacological potential in type 2 diabetes (T2D) treatment, notably by improving β cell functions. The cell-cycle regulator and transcription factor E2f1 is involved in glucose ... ...

    Abstract The glucagon-like peptide 1 (Glp-1) has emerged as a hormone with broad pharmacological potential in type 2 diabetes (T2D) treatment, notably by improving β cell functions. The cell-cycle regulator and transcription factor E2f1 is involved in glucose homeostasis by modulating β cell mass and function. Here, we report that β cell-specific genetic ablation of E2f1 (E2f1
    MeSH term(s) Diabetes Mellitus, Type 2/metabolism ; E2F1 Transcription Factor/genetics ; E2F1 Transcription Factor/metabolism ; Exenatide/pharmacology ; Glucagon-Like Peptide-1 Receptor/metabolism ; Glucose/metabolism ; Humans ; Insulin/metabolism ; Insulin-Secreting Cells/metabolism
    Chemical Substances E2F1 Transcription Factor ; E2F1 protein, human ; Glucagon-Like Peptide-1 Receptor ; Insulin ; Exenatide (9P1872D4OL) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-08-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2022.111170
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pharmacological HDAC inhibition impairs pancreatic β-cell function through an epigenome-wide reprogramming.

    Oger, Frédérik / Moreno, Maeva / Derhourhi, Mehdi / Thiroux, Bryan / Berberian, Lionel / Bourouh, Cyril / Durand, Emmanuelle / Amanzougarene, Souhila / Badreddine, Alaa / Blanc, Etienne / Molendi-Coste, Olivier / Pineau, Laurent / Pasquetti, Gianni / Rolland, Laure / Carney, Charlène / Bornaque, Florine / Courty, Emilie / Gheeraert, Céline / Eeckhoute, Jérôme /
    Dombrowicz, David / Kerr-Conte, Julie / Pattou, François / Staels, Bart / Froguel, Philippe / Bonnefond, Amélie / Annicotte, Jean-Sébastien

    iScience

    2023  Volume 26, Issue 7, Page(s) 107231

    Abstract: Histone deacetylases enzymes (HDACs) are chromatin modifiers that regulate gene expression through deacetylation of lysine residues within specific histone and non-histone proteins. A cell-specific gene expression pattern defines the identity of insulin- ... ...

    Abstract Histone deacetylases enzymes (HDACs) are chromatin modifiers that regulate gene expression through deacetylation of lysine residues within specific histone and non-histone proteins. A cell-specific gene expression pattern defines the identity of insulin-producing pancreatic β cells, yet molecular networks driving this transcriptional specificity are not fully understood. Here, we investigated the HDAC-dependent molecular mechanisms controlling pancreatic β-cell identity and function using the pan-HDAC inhibitor trichostatin A through chromatin immunoprecipitation assays and RNA sequencing experiments. We observed that TSA alters insulin secretion associated with β-cell specific transcriptome programming in both mouse and human β-cell lines, as well as on human pancreatic islets. We also demonstrated that this alternative β-cell transcriptional program in response to HDAC inhibition is related to an epigenome-wide remodeling at both promoters and enhancers. Our data indicate that HDAC activity could be required to protect against loss of β-cell identity with unsuitable expression of genes associated with alternative cell fates.
    Language English
    Publishing date 2023-06-30
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.107231
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: β-Cell-Specific E2f1 Deficiency Impairs Glucose Homeostasis, β-Cell Identity, and Insulin Secretion.

    Oger, Frédérik / Bourouh, Cyril / Friano, Marika Elsa / Courty, Emilie / Rolland, Laure / Gromada, Xavier / Moreno, Maeva / Carney, Charlène / Rabhi, Nabil / Durand, Emmanuelle / Amanzougarene, Souhila / Berberian, Lionel / Derhourhi, Mehdi / Blanc, Etienne / Hannou, Sarah Anissa / Denechaud, Pierre-Damien / Benfodda, Zohra / Meffre, Patrick / Fajas, Lluis /
    Kerr-Conte, Julie / Pattou, François / Froguel, Philippe / Pourcet, Benoit / Bonnefond, Amélie / Collombat, Patrick / Annicotte, Jean-Sébastien

    Diabetes

    2023  Volume 72, Issue 8, Page(s) 1112–1126

    Abstract: The loss of pancreatic β-cell identity has emerged as an important feature of type 2 diabetes development, but the molecular mechanisms are still elusive. Here, we explore the cell-autonomous role of the cell-cycle regulator and transcription factor E2F1 ...

    Abstract The loss of pancreatic β-cell identity has emerged as an important feature of type 2 diabetes development, but the molecular mechanisms are still elusive. Here, we explore the cell-autonomous role of the cell-cycle regulator and transcription factor E2F1 in the maintenance of β-cell identity, insulin secretion, and glucose homeostasis. We show that the β-cell-specific loss of E2f1 function in mice triggers glucose intolerance associated with defective insulin secretion, altered endocrine cell mass, downregulation of many β-cell genes, and concomitant increase of non-β-cell markers. Mechanistically, epigenomic profiling of the promoters of these non-β-cell upregulated genes identified an enrichment of bivalent H3K4me3/H3K27me3 or H3K27me3 marks. Conversely, promoters of downregulated genes were enriched in active chromatin H3K4me3 and H3K27ac histone marks. We find that specific E2f1 transcriptional, cistromic, and epigenomic signatures are associated with these β-cell dysfunctions, with E2F1 directly regulating several β-cell genes at the chromatin level. Finally, the pharmacological inhibition of E2F transcriptional activity in human islets also impairs insulin secretion and the expression of β-cell identity genes. Our data suggest that E2F1 is critical for maintaining β-cell identity and function through sustained control of β-cell and non-β-cell transcriptional programs.
    Article highlights: β-Cell-specific E2f1 deficiency in mice impairs glucose tolerance. Loss of E2f1 function alters the ratio of α- to β-cells but does not trigger β-cell conversion into α-cells. Pharmacological inhibition of E2F activity inhibits glucose-stimulated insulin secretion and alters β- and α-cell gene expression in human islets. E2F1 maintains β-cell function and identity through control of transcriptomic and epigenetic programs.
    MeSH term(s) Animals ; Humans ; Mice ; Chromatin/metabolism ; Diabetes Mellitus, Type 2/genetics ; Diabetes Mellitus, Type 2/metabolism ; Glucose/metabolism ; Histones/metabolism ; Homeostasis/genetics ; Insulin/metabolism ; Insulin Secretion ; Insulin-Secreting Cells/metabolism ; Mice, Knockout
    Chemical Substances Chromatin ; Glucose (IY9XDZ35W2) ; Histones ; Insulin ; E2F1 protein, human ; E2f1 protein, mouse
    Language English
    Publishing date 2023-05-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80085-5
    ISSN 1939-327X ; 0012-1797
    ISSN (online) 1939-327X
    ISSN 0012-1797
    DOI 10.2337/db22-0604
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model.

    Benderradji, Hamza / Kraiem, Sarra / Courty, Emilie / Eddarkaoui, Sabiha / Bourouh, Cyril / Faivre, Emilie / Rolland, Laure / Caron, Emilie / Besegher, Mélanie / Oger, Frederik / Boschetti, Theo / Carvalho, Kévin / Thiroux, Bryan / Gauvrit, Thibaut / Nicolas, Emilie / Gomez-Murcia, Victoria / Bogdanova, Anna / Bongiovanni, Antonino / Muhr-Tailleux, Anne /
    Lancel, Steve / Bantubungi, Kadiombo / Sergeant, Nicolas / Annicotte, Jean-Sebastien / Buée, Luc / Vieau, Didier / Blum, David / Buée-Scherrer, Valérie

    Frontiers in molecular neuroscience

    2022  Volume 15, Page(s) 841892

    Abstract: Alzheimer's disease (AD) is the leading cause of dementia. While impaired glucose homeostasis has been shown to increase AD risk and pathological loss of tau function, the latter has been suggested to contribute to the emergence of the glucose ... ...

    Abstract Alzheimer's disease (AD) is the leading cause of dementia. While impaired glucose homeostasis has been shown to increase AD risk and pathological loss of tau function, the latter has been suggested to contribute to the emergence of the glucose homeostasis alterations observed in AD patients. However, the links between tau impairments and glucose homeostasis, remain unclear. In this context, the present study aimed at investigating the metabolic phenotype of a new tau knock-in (KI) mouse model, expressing, at a physiological level, a human tau protein bearing the P301L mutation under the control of the endogenous mouse
    Language English
    Publishing date 2022-02-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2452967-9
    ISSN 1662-5099
    ISSN 1662-5099
    DOI 10.3389/fnmol.2022.841892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Adaptive β-Cell Neogenesis in the Adult Mouse in Response to Glucocorticoid-Induced Insulin Resistance.

    Courty, Emilie / Besseiche, Adrien / Do, Thi Thu Huong / Liboz, Alexandrine / Aguid, Fatima Mohamed / Quilichini, Evans / Buscato, Melissa / Gourdy, Pierre / Gautier, Jean-François / Riveline, Jean-Pierre / Haumaitre, Cécile / Buyse, Marion / Fève, Bruno / Guillemain, Ghislaine / Blondeau, Bertrand

    Diabetes

    2018  Volume 68, Issue 1, Page(s) 95–108

    Abstract: Both type 1 and type 2 diabetes are characterized by deficient insulin secretion and decreased β-cell mass. Thus, regenerative strategies to increase β-cell mass need to be developed. To characterize mechanisms of β-cell plasticity, we studied a model of ...

    Abstract Both type 1 and type 2 diabetes are characterized by deficient insulin secretion and decreased β-cell mass. Thus, regenerative strategies to increase β-cell mass need to be developed. To characterize mechanisms of β-cell plasticity, we studied a model of severe insulin resistance in the adult mouse and defined how β-cells adapt. Chronic corticosterone (CORT) treatment was given to adult mice and led to rapid insulin resistance and adaptive increased insulin secretion. Adaptive and massive increase of β-cell mass was observed during treatment up to 8 weeks. β-Cell mass increase was partially reversible upon treatment cessation and reinduced upon subsequent treatment. β-Cell neogenesis was suggested by an increased number of islets, mainly close to ducts, and increased Sox9 and Ngn3 mRNA levels in islets, but lineage-tracing experiments revealed that neoformed β-cells did not derive from Sox9- or Ngn3-expressing cells. CORT treatment after β-cell depletion partially restored β-cells. Finally, β-cell neogenesis was shown to be indirectly stimulated by CORT because serum from CORT-treated mice increased β-cell differentiation in in vitro cultures of pancreatic buds. Altogether, the results present a novel model of β-cell neogenesis in the adult mouse and identify the presence of neogenic factors in the serum of CORT-treated mice.
    MeSH term(s) Animals ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Diabetes Mellitus, Type 1/genetics ; Diabetes Mellitus, Type 2/genetics ; Female ; Flow Cytometry ; Glucocorticoids/pharmacology ; Insulin Resistance/genetics ; Insulin Resistance/physiology ; Insulin-Secreting Cells/drug effects ; Insulin-Secreting Cells/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Nerve Tissue Proteins/genetics ; SOX9 Transcription Factor/genetics
    Chemical Substances Basic Helix-Loop-Helix Transcription Factors ; Glucocorticoids ; Nerve Tissue Proteins ; Neurog3 protein, mouse ; SOX9 Transcription Factor
    Language English
    Publishing date 2018-10-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80085-5
    ISSN 1939-327X ; 0012-1797
    ISSN (online) 1939-327X
    ISSN 0012-1797
    DOI 10.2337/db17-1314
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top